Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Operating Expenses (2020 - 2025)

Historic Operating Expenses for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$22.0 million.

  • SOPHiA GENETICS's Operating Expenses fell 1707.37% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.3 million, marking a year-over-year decrease of 331.6%. This contributed to the annual value of -$81.3 million for FY2024, which is 991.58% up from last year.
  • SOPHiA GENETICS's Operating Expenses amounted to -$22.0 million in Q3 2025, which was down 1707.37% from -$20.8 million recorded in Q2 2025.
  • SOPHiA GENETICS's Operating Expenses' 5-year high stood at -$14.6 million during Q2 2021, with a 5-year trough of -$23.9 million in Q1 2022.
  • For the 5-year period, SOPHiA GENETICS's Operating Expenses averaged around -$20.8 million, with its median value being -$21.7 million (2023).
  • In the last 5 years, SOPHiA GENETICS's Operating Expenses skyrocketed by 9979.95% in 2021 and then crashed by 6213.98% in 2022.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Operating Expenses stood at -$19.3 million in 2021, then decreased by 7.26% to -$20.7 million in 2022, then decreased by 11.14% to -$23.0 million in 2023, then rose by 5.3% to -$21.8 million in 2024, then fell by 0.68% to -$22.0 million in 2025.
  • Its last three reported values are -$22.0 million in Q3 2025, -$20.8 million for Q2 2025, and -$20.7 million during Q1 2025.